Biblio

Journal Article
Cazeau N, Rodriguez SL. Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease. Clin J Oncol Nurs. 2023;27(4):397-403.
Li A-A, Yu Y-Y, Gao X-M, Zhao H, Cao X-X, Zhang L, Bin Zhou D-, Li J. Treatment and outcome of second-line therapy for POEMS syndrome after autologous stem cell transplantation. Bone Marrow Transplant. 2023.
Lee AChi-Wai, Chui CHon, Kwok R, Lee KShang, Fong CMeng, Wong WHs. Treatment and outcomes of high-risk neuroblastoma in Southeast Asia: a single institution experience and review of the literature. Singapore Med J. 2021.
Hodowanec AC, Pikis A, Komatsu TE, Sampson MR, Younis IR, O'Rear JJ, Singer ME. Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives. J Clin Pharmacol. 2018.
Mocikova H, Sýkorová A, Stěpánková P, Marková J, Michalka J, Král Z, Burešová L, Belada D. [Treatment and Prognosis of Relapsed or Refractory Hodgkin Lymphoma Patients Ineligible for Stem Cell Transplantation.]. Klin Onkol. 2014;27(6):424-428.
Bradley JA, Kayton ML, Chi Y-Y, Hawkins DS, Tian J, Breneman J, Wolden SL, Walterhouse D, Rodeberg DA, Donaldson SS. Treatment Approach and Outcomes in Infants with Localized Rhabdomyosarcoma: A Report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2018.
Lin C-M, Chang L-C, Shau W-Y, Chen C-L, Yao C-Y, Tien F-M. Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis. BMC Cancer. 2023;23(1):446.
Booth A, Bonham V, Porteus M, Ormond KE. Treatment decision-making in sickle cell disease patients. J Community Genet. 2021.
Hughes CL, Yorio JT, Kovitz C, Oki Y. Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barre syndrome: a case report. J Med Case Rep. 2014;8(1):455.
Jecrois ES, Zheng W, Bornhorst M, Li Y, Treisman DM, Muguyo D, Huynh S, Andrew SF, Wang Y, Jiang J, et al. Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors. Dev Cell. 2021.
Lightner AL, Pineiro AOtero, Reese J, Ream J, Nachand D, Adams AC, Dadgar N, Hull T. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn disease are durable at 12 months. Surgery. 2023.
Schelbergen RF, van Dalen S, Huurne MCTer, Sloetjes A, Roth J, Vogl T, Noël D, Jorgensen C, van den Berg WB, van der Kraan PM, et al. Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels. Osteoarthritis Cartilage. 2014.
Chen Y, Pan C, Xuan A, Xu L, Bao G, Liu F, Fang J, Long D. Treatment Efficacy of NGF Nanoparticles Combining Neural Stem Cell Transplantation on Alzheimer's Disease Model Rats. Med Sci Monit. 2015;21:3608-3615.
Idriss NK, Sayyed HG, Osama A, Sabry D. Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model. Cell Physiol Biochem. 2018;48(5):2161-2171.
Sherman MA, Kim H, Banschbach K, Brown A, Gewanter HL, Lang B, Perron M, Robinson AByun, Spitznagle J, Stingl C, et al. Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance. Pediatr Rheumatol Online J. 2023;21(1):3.
Mirfakhraie R, Noorazar L, Mohammadian M, Hajifathali A, Gholizadeh M, Salimi M, Sankanian G, Roshandel E, Mehdizadeh M. Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles. Leuk Res. 2021;112:106751.
Rostamzadeh F, Jafarinejad-Farsangi S, Ansari-Asl Z, Farrokhi MShadkam, Jafari E. Treatment for myocardial infarction: in vivo evaluation of curcumin-loaded PEGylated-GQDs nanoparticles. J Cardiovasc Pharmacol. 2023.
Longval T, Galimard J-E, Leprêtre A-C, Suarez F, Amiranoff D, Cazaux M, Kaphan E, Michonneau D, Dhedin N, Coman T, et al. Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study. Br J Haematol. 2021.
Shibuya Y, Kumar KK, Mader MMarc-Danie, Yoo Y, Ayala LAngel, Zhou M, Mohr MAlexander, Neumayer G, Kumar I, Yamamoto R, et al. Treatment of a genetic brain disease by CNS-wide microglia replacement. Sci Transl Med. 2022;14(636):eabl9945.
Fitzpatrick N, Black C, Choucourn M, Blunn G, Meswania J, Sanghani-Kerai A. Treatment of a large osseous defect in a feline tarsus using a stem cell-seeded custom implant. J Tissue Eng Regen Med. 2020.
Völker LA, Brinkkoetter PT, Knöbl P, Krstic M, Kaufeld J, Menne J, Buxhofer-Ausch V, Miesbach W. Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab. J Thromb Haemost. 2020.
Chen Y-S, Kong X-J, Zhang X-H, Yin X-L. Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation. Bone Marrow Transplant. 2014.
Mayer K, Serries M, Hahn-Ast C, Bisht S, Brossart P, Feldmann G. Treatment of acute myeloid leukaemia in older patients - scope of intensive therapy? - A retrospective analysis. Hematology. 2023;28(1):2212536.
Egan G, Chopra Y, Mourad S, Chiang K-Y, Hitzler J. Treatment of acute myeloid leukemia in children: A practical perspective. Pediatr Blood Cancer. 2021:e28979.
Schubert M-L, Schmitt A, Hückelhoven-Krauss A, Neuber B, Kunz A, Waldhoff P, Vonficht D, Yousefian S, Jopp-Saile L, Wang L, et al. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial. J Hematol Oncol. 2023;16(1):79.

Pages